Unicycive Therapeutics Inc
About
Unicycive Therapeutics Inc (NASDAQ:UNCY) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 9 2026
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 30 2026
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Feb 4 2026
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
Jan 29 2026
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Jan 29 2026
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Financials
Revenue
$0
Market Cap
$174.9 M
EPS
-1.67